Ning Su

Department of Hematology, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China., China (People's Republic)

Poster(s):

• 1408 - Optimizing Time-Limited Therapy in Unfit CLL/SLL Patients: Orelabrutinib, Bendamustine, and Obinutuzumab Combination (OBG) Regimen